← Back to all trials
Recruiting
NCT06858787
Validating CGM for GDM
Conditions: Gestational Diabetes Mellitus (GDM)
Sex: Female
Ages: 18 Years – 50 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 150
Sponsor: Icahn School of Medicine at Mount Sinai
Location: Mount Sinai West New York New York
Summary
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Eligibility Criteria
Inclusion Criteria:
* Ages 18-50
* Singleton pregnancy between 24-32 weeks gestational age
* Prenatal care and delivery at Mount Sinai Hospital
Exclusion Criteria:
* Multiple fetal gestation
* Preexisting diabetes
* Concurrent use of steroids
* Anomalous fetus
* Insufficient prenatal care (identified as missing half the recommended visits or establishing care after 20 weeks gestation)
* Unable to tolerate oral glucose test
Source: ClinicalTrials.gov (NCT06858787). StuddyBuddy aggregates publicly available trial information.
